Which company is targeting a $3-4 billion SPAC and what do Pfizer, AstraZeneca, Merck, and Teva all have in common?
REE Automotive in negotiations for a $3-4 billion Nasdaq SPAC merger. The Israeli developer of modular platforms for electric vehicles has been negotiating the move for more than three months and the deal could be completed in January. Read more Pfizer, AstraZeneca, Merck, and Teva win tender for new Israeli Innovation Lab. The lab, which is set to research digital health and computational biology, has a government budget of $9.9 million. Read more HR Post Covid | Compassion is “more important than ever” during Covid-19, says Pecan HR head. Understanding what your employees ne...
Source: calcalistech.com